mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
Shun Qing Liang, Elias D. Bührer, Sabina Berezowska, Thomas M. Marti, Duo Xu, Laurène Froment, Haitang Yang, Sean R.R. Hall, Erik Vassella, Zhang Yang, Gregor J. Kocher, Michael A. Amrein, Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Ren Wang Peng
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer'. Together they form a unique fingerprint.